Brent L. Larson
2009
In 2009, Brent L. Larson earned a total compensation of $351.9K as Senior Vice President and Chief Financial Officer at Navidea Biopharmaceuticals, a 53% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $15,313 |
---|---|
Option Awards | $65,247 |
Salary | $184,000 |
Stock Awards | $82,426 |
Other | $4,934 |
Total | $351,920 |
Larson received $184K in salary, accounting for 52% of the total pay in 2009.
Larson also received $15.3K in non-equity incentive plan, $65.2K in option awards, $82.4K in stock awards and $4.9K in other compensation.
Rankings
In 2009, Brent L. Larson's compensation ranked 7,926th out of 9,885 executives tracked by ExecPay. In other words, Larson earned more than 19.8% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,926 out of 9,885 | 20th |
Division Manufacturing | 2,966 out of 3,690 | 20th |
Major group Chemicals And Allied Products | 675 out of 866 | 22nd |
Industry group Drugs | 484 out of 638 | 24th |
Industry In Vitro and In Vivo Diagnostic Substances | 30 out of 44 | 32nd |
Source: SEC filing on July 10, 2012.
Larson's colleagues
We found three more compensation records of executives who worked with Brent L. Larson at Navidea Biopharmaceuticals in 2009.